Funder directory / Germany / Corporate VCs
M Ventures
SaveM Ventures is the strategic corporate venture capital fund of Merck KGaA, investing with dual strategic and financial focus in biotechnology and technology companies. The site cites a €600m fund allocation and more than 100 total investments since 2009.
StagesNot stated
What they invest in
Mentioned in reports (7)
- Growth Equity Update - August 2026 (Edition 53)Rothschild & Co · August 2026 · 26 pages
- Venture Capital Report - Italy Q3 2026Growth Capital · January 2026 · 62 pages
- Swiss Venture Capital Report 2026SECA (Swiss Private Equity and Corporate Finance Association) · January 2026 · 88 pages
- Swiss Venture Capital Report 2025SECA (Swiss Private Equity and Corporate Finance Association) · January 2025 · 84 pages
- Swiss Venture Capital Report 2024Swiss Venture Capital Report (startupticker) · January 2024 · 88 pages
- Swiss Venture Capital Report 2022Swiss Venture Capital Report (startupticker) · January 2022 · 80 pages
- Swiss Venture Capital Report 2020Swiss Venture Capital Report (startupticker) · January 2020 · 76 pages
Reports by other publishers that name M Ventures.
Similar funders
- BASF Venture Capital GmbH · Corporate venture capital, Germany
- Bosch Ventures · Corporate venture capital, Germany
- Robert Bosch Venture Capital GmbH · Corporate venture capital, Germany
- Oscar & Paul Beiersdorf Venture Capital · Corporate venture capital, Germany
- Phoenix Contact Innovation Ventures · Corporate venture capital, Germany
- Statkraft Ventures · Corporate venture capital, Germany